Your browser doesn't support javascript.
loading
Real-world prognostic testing and treatment patterns in CLL/SLL: results from 1462 patients in the informCLL registry.
Mato, Anthony R; Ghosh, Nilanjan; Sharman, Jeff P; Brander, Danielle; Gutierrez, Meghan; Huang, Qing; Wu, Linda H; Young, Alex; Upasani, Sandhya; Naganuma, Maoko; Barrientos, Jacqueline C.
Affiliation
  • Mato AR; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Ghosh N; Levine Cancer Institute, Atrium Health, Charlotte, NC.
  • Sharman JP; Willamette Valley Cancer Institute & Research Center, Eugene, OR.
  • Brander D; Duke University Health System, Durham, NC.
  • Gutierrez M; Lymphoma Research Foundation, New York, NY.
  • Huang Q; Janssen Scientific Affairs, LLC, Horsham, PA.
  • Wu LH; Janssen Scientific Affairs, LLC, Horsham, PA.
  • Young A; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA.
  • Upasani S; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA.
  • Naganuma M; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA.
  • Barrientos JC; Mount Sinai Medical Center, Miami Beach, FL.
Blood Adv ; 7(17): 4760-4764, 2023 09 12.
Article in En | MEDLINE | ID: mdl-36206191

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell Type of study: Prognostic_studies Limits: Humans Language: En Journal: Blood Adv Year: 2023 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell Type of study: Prognostic_studies Limits: Humans Language: En Journal: Blood Adv Year: 2023 Document type: Article Country of publication: United States